Login / Signup

How we approach hemangiomas in infants.

Jennifer L R MayerStefanos IntzesVikash S OzaFrancine Blei
Published in: Pediatric blood & cancer (2021)
Pediatric oncologists are increasingly involved in the management of benign vascular tumors and their associated life-threatening complications. Hemangiomas are the most common referring diagnosis to multidisciplinary vascular anomalies clinics. However, as contemporary research has revealed, hemangiomas are not a single, easily defined entity but rather a diverse set of related vascular tumors, each having a unique natural history, growth pattern, and response to therapy. This manuscript seeks to illustrate how we evaluate and manage these complex tumors, their complications, and associated syndromes, while remaining ever vigilant for malignant hemangioma mimickers such as soft tissue sarcomas and congenital leukemia.
Keyphrases
  • soft tissue
  • risk factors
  • primary care
  • bone marrow
  • acute myeloid leukemia
  • stem cells
  • single cell
  • young adults
  • quality improvement
  • cell therapy